GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (OTCPK:IPDQF) » Definitions » Days Payable

IPDQF (Impedimed) Days Payable : 483.04 (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Impedimed Days Payable?

Impedimed's average Accounts Payable for the six months ended in Jun. 2024 was $1.20 Mil. Impedimed's Cost of Goods Sold for the six months ended in Jun. 2024 was $0.45 Mil. Hence, Impedimed's Days Payable for the six months ended in Jun. 2024 was 483.04.

The historical rank and industry rank for Impedimed's Days Payable or its related term are showing as below:

IPDQF' s Days Payable Range Over the Past 10 Years
Min: 209.52   Med: 427.52   Max: 670.82
Current: 457.96

During the past 13 years, Impedimed's highest Days Payable was 670.82. The lowest was 209.52. And the median was 427.52.

IPDQF's Days Payable is ranked better than
92.3% of 792 companies
in the Medical Devices & Instruments industry
Industry Median: 70.18 vs IPDQF: 457.96

Impedimed's Days Payable declined from Jun. 2023 (554.72) to Jun. 2024 (483.04). It may suggest that Impedimed accelerated paying its suppliers.


Impedimed Days Payable Historical Data

The historical data trend for Impedimed's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed Days Payable Chart

Impedimed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 436.39 344.29 432.32 485.79 342.61

Impedimed Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 513.70 657.60 554.72 556.34 483.04

Competitive Comparison of Impedimed's Days Payable

For the Medical Devices subindustry, Impedimed's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Impedimed's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Impedimed's Days Payable distribution charts can be found below:

* The bar in red indicates where Impedimed's Days Payable falls into.



Impedimed Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Impedimed's Days Payable for the fiscal year that ended in Jun. 2024 is calculated as

Days Payable (A: Jun. 2024 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Jun. 2023 ) + Accounts Payable (A: Jun. 2024 )) / count ) / Cost of Goods Sold (A: Jun. 2024 )*Days in Period
=( (0.909 + 0.728) / 2 ) / 0.872*365
=0.8185 / 0.872*365
=342.61

Impedimed's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

Days Payable (Q: Jun. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Jun. 2024 )) / count ) / Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=( (1.67 + 0.728) / 2 ) / 0.453*365 / 2
=1.199 / 0.453*365 / 2
=483.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Impedimed Days Payable Related Terms

Thank you for viewing the detailed overview of Impedimed's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Impedimed Business Description

Traded in Other Exchanges
Address
50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

Impedimed Headlines

From GuruFocus

Q2 2022 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Ordinary Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Half Year 2024 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 09-14-2024

Q2 2023 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Investor Conference Call Transcript

By GuruFocus Research 02-14-2024

Q1 2024 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Ordinary Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Q4 2023 ImpediMed Ltd Cashflow Reports Call Transcript

By GuruFocus Research 02-14-2024